(Q38096495)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Role of proteoglycans in the regulation of the skeletal muscle fibrotic response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Jaime Gutierrez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

2 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

4109-4117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Functions of cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Heparan sulfates in skeletal muscle development and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Proteoglycans in health and disease: emerging concepts and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Aberrant repair and fibrosis development in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Postnatal changes in sarcolemmal organization in the mdx mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Regulation and dysregulation of fibrosis in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Cellular and molecular mechanisms of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor beta and accelerates skeletal muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Type beta transforming growth factor is an inhibitor of myogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

How cells read TGF-beta signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Human connective tissue growth factor is expressed in advanced atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Expression of connective tissue growth factor in experimental rat and human liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Decorin and biglycan expression is differentially altered in several muscular dystrophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-beta and CTGF/CCN2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor (CCN2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Functions and mechanisms of action of CCN matricellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Hypoxic induction of Ctgf is directly mediated by Hif-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Profibrotic effects of endothelin-1 via the ETA receptor in cultured human cardiac fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Renin-angiotensin system in the pathogenesis of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

TGF-beta and fibrosis in different organs - molecular pathway imprints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Decorin gene transfer promotes muscle cell differentiation and muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Hormones, growth factors, and myogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent signaling, and inhibits TGF-β-dependent fibrotic response in skeletal musc

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

The low density lipoprotein receptor-related protein functions as an endocytic receptor for decorin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Decorin binds myostatin and modulates its activity to muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Connective tissue growth factor binds to fibronectin through the type I repeat modules and enhances the affinity of fibronectin to fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Matrix metalloproteinase-2-deficient fibroblasts exhibit an alteration in the fibrotic response to connective tissue growth factor/CCN2 because of an increase in the levels of endogenous fibronectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Matricellular proteins: extracellular modulators of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Connective tissue growth factor: context-dependent functions and mechanisms of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

CCN2/decorin interactions: a novel approach to combating fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

The low density lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12278

21 January 2018

Identifiers

DOI

10.1111/FEBS.12278

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23560928%20AND%20SRC:MED&resulttype=core&format=json